146 related articles for article (PubMed ID: 15710815)
21. Visual field progression in glaucoma: total versus pattern deviation analyses.
Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
[TBL] [Abstract][Full Text] [Related]
22. Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss.
Cirineo N; Morales E; Lee JM; Ramanathan M; Hirunpatravong P; Lin M; Capistrano V; Abdelmonen A; Yu F; Nouri-Mahdavi K; Coleman AL; Caprioli J
J Glaucoma; 2017 Oct; 26(10):902-910. PubMed ID: 28858161
[TBL] [Abstract][Full Text] [Related]
23. Relationship between asymmetric central corneal thickness and glaucomatous visual field loss within the same patient.
Sullivan-Mee M; Gentry JM; Qualls C
Optom Vis Sci; 2006 Jul; 83(7):516-9. PubMed ID: 16840876
[TBL] [Abstract][Full Text] [Related]
24. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.
Am J Ophthalmol; 2000 Oct; 130(4):429-40. PubMed ID: 11024415
[TBL] [Abstract][Full Text] [Related]
25. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for visual field progression in treated glaucoma.
De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
[TBL] [Abstract][Full Text] [Related]
27. Fellow eye prognosis in patients with severe visual field loss in 1 eye from chronic open-angle glaucoma.
Chen PP; Bhandari A
Arch Ophthalmol; 2000 Apr; 118(4):473-8. PubMed ID: 10766132
[TBL] [Abstract][Full Text] [Related]
28. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability.
Ophthalmology; 1994 Aug; 101(8):1445-55. PubMed ID: 7741836
[TBL] [Abstract][Full Text] [Related]
29. Rate of visual field progression in eyes with optic disc hemorrhages in the ocular hypertension treatment study.
De Moraes CG; Demirel S; Gardiner SK; Liebmann JM; Cioffi GA; Ritch R; Gordon MO; Kass MA
Arch Ophthalmol; 2012 Dec; 130(12):1541-6. PubMed ID: 23229692
[TBL] [Abstract][Full Text] [Related]
30. Correlation of visual field progression between eyes in patients with open-angle glaucoma.
Chen PP
Ophthalmology; 2002 Nov; 109(11):2093-9. PubMed ID: 12414421
[TBL] [Abstract][Full Text] [Related]
31. Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease.
Ang LP; Aung T; Chua WH; Yip LW; Chew PT
Ophthalmology; 2004 Sep; 111(9):1636-40. PubMed ID: 15350315
[TBL] [Abstract][Full Text] [Related]
32. Progression detection capability of macular thickness in advanced glaucomatous eyes.
Sung KR; Sun JH; Na JH; Lee JY; Lee Y
Ophthalmology; 2012 Feb; 119(2):308-13. PubMed ID: 22182800
[TBL] [Abstract][Full Text] [Related]
33. Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.
Chauhan BC; Nicolela MT; Artes PH
Ophthalmology; 2009 Nov; 116(11):2110-8. PubMed ID: 19500850
[TBL] [Abstract][Full Text] [Related]
34. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls.
Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
JAMA Ophthalmol; 2013 Dec; 131(12):1565-72. PubMed ID: 24177807
[TBL] [Abstract][Full Text] [Related]
35. Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database.
Asano S; Murata H; Matsuura M; Fujino Y; Miki A; Tanito M; Mizoue S; Mori K; Suzuki K; Yamashita T; Kashiwagi K; Shoji N; Zangwill LM; Asaoka R
Br J Ophthalmol; 2020 Apr; 104(4):569-574. PubMed ID: 31272952
[TBL] [Abstract][Full Text] [Related]
36. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
[TBL] [Abstract][Full Text] [Related]
37. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
[TBL] [Abstract][Full Text] [Related]
38. Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).
O'Leary N; Chauhan BC; Artes PH
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6776-84. PubMed ID: 22952123
[TBL] [Abstract][Full Text] [Related]
39. Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss.
Spry PG; Johnson CA; Bates AB; Turpin A; Chauhan BC
Arch Ophthalmol; 2002 Feb; 120(2):173-80. PubMed ID: 11831919
[TBL] [Abstract][Full Text] [Related]
40. Monitoring glaucomatous visual field progression: the effect of a novel spatial filter.
Strouthidis NG; Scott A; Viswanathan AC; Crabb DP; Garway-Heath DF
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):251-7. PubMed ID: 17197540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
